verapamil has been researched along with nutlin 1 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
He, Q; Hu, Y; Wang, W; Yan, Y; Yang, B; Yang, W; Zhang, L; Zhu, D | 1 |
1 other study(ies) available for verapamil and nutlin 1
Article | Year |
---|---|
Nutlin-1 strengthened anti-proliferation and differentiation-inducing activity of ATRA in ATRA-treated p-glycoprotein deregulated human myelocytic leukemia cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Biological Transport; CCAAT-Enhancer-Binding Protein-beta; Cell Differentiation; Cell Proliferation; Dose-Response Relationship, Drug; Drug Synergism; HL-60 Cells; Humans; Imidazoles; Leukemia, Myeloid; Piperazines; Proto-Oncogene Proteins c-mdm2; Proto-Oncogene Proteins c-myc; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; RNA Interference; Time Factors; Transfection; Tretinoin; Tumor Suppressor Protein p53; U937 Cells; Verapamil | 2012 |